about
Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myelomaDermatan Sulfate-Free Mice Display Embryological Defects and Are Neonatal Lethal Despite Normal Lymphoid and Non-Lymphoid OrganogenesisA Reproducible Method for Isolation and In Vitro Culture of Functional Human Lymphoid Stromal Cells from TonsilsN-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation.Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma.The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells.Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria.Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation.Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis.Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of Inflammation.Dendritic Cell Migration to Skin-Draining Lymph Nodes Is Controlled by Dermatan Sulfate and Determines Adaptive Immunity Magnitude.Impaired lymphoid organ development in mice lacking the heparan sulfate modifying enzyme glucuronyl C5-epimerase.Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival.IL-7-dependent maintenance of ILC3s is required for normal entry of lymphocytes into lymph nodes.Loss of IL-22 inhibits autoantibody formation in collagen-induced arthritis in mice.MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphomaInstant conditional transgenesis in the mouse hematopoietic compartmentCD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell PrecursorsMutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaFramework engineering to produce dominant T cell receptors with enhanced antigen-specific functionLymph Node Stromal Cells Generate Antigen-Specific Regulatory T Cells and Control Autoreactive T and B Cell ResponsesSimultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic
P50
Q27001749-87B64CD0-83AF-4315-80F7-6E49FC7D7D2CQ35816218-21370299-6E97-4C11-83E2-76CCCE25DFEDQ36210450-67D8BDA8-BC36-4FB3-8877-F3F2DE85BFBBQ38949755-994C260E-B351-42F5-98FF-63420AE686CBQ39413604-961B55C3-F2F6-45FF-BC49-247E0738F5F7Q39766374-8A128006-4D07-4B9D-94F6-7E10A2F659A3Q40019616-AA05BADD-9716-4380-B8AD-9002F86376DAQ40046334-8244915F-17EA-49FE-BF94-E9A4F0E195BEQ42095379-21E0BC19-ADE3-4D02-9738-2D1047B6515DQ42291940-24ED644F-D7B3-4749-A7CA-E7A56494DC07Q50090115-A90799B4-4CEC-4CA1-80A9-E26C699BC547Q50334388-57E4136F-A9B9-4B3D-A364-0BB1F98FD8F6Q51913435-635D6407-2BE9-4740-96EE-7FAA4D50CEB2Q52562611-DB35E60B-0F85-4622-B0DF-032A1441E57DQ52609801-47CC59E1-9F2C-4393-B342-4D29388CE3F2Q52730877-2F42C2DC-5F8B-4CFD-A8B6-6EAF7457DAD4Q53148065-285B146F-6C3A-4F4B-AD07-62F3FE83765BQ57272181-D7BFD7F8-B402-40E1-BBDA-ACB8634D136BQ58324012-45CBF9E0-4E82-4018-B1F6-050EAA7363E7Q60251040-164201CD-1C18-4B4C-8515-57F78B7A0FE6Q64229918-61111FB1-7FC0-471A-9197-28AC064A1F3BQ90425510-ADA645D9-1ED5-4C84-8398-6A9FEE576669Q90628408-268C2331-565A-4568-89DE-660C098DFEDCQ90855852-844E83FD-2E00-4920-9CC2-28C4B3E67F25
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rogier M Reijmers
@es
Rogier M. Reijmers
@en
Rogier M. Reijmers
@nl
Rogier M. Reijmers
@sl
type
label
Rogier M Reijmers
@es
Rogier M. Reijmers
@en
Rogier M. Reijmers
@nl
Rogier M. Reijmers
@sl
prefLabel
Rogier M Reijmers
@es
Rogier M. Reijmers
@en
Rogier M. Reijmers
@nl
Rogier M. Reijmers
@sl
P106
P1153
8343728800
P21
P2798
P31
P3835
rogier-reijmers
P496
0000-0001-7471-7715
P569
2000-01-01T00:00:00Z